Cell And Gene Therapy Manufacturing
-
Genentech, Myeloid's Approaches To mRNA Technologies
1/29/2024
Experts at a Cell & Gene Live event discussed the use of mRNA technology in cancer immunotherapy, including a brief overview of the different approaches being used to leverage mRNA technology.
-
Scalable By Design: Streamlining Cell Culture Media Manufacturing
8/15/2024
Learn ways to help improve quality, simplify technology transfer of proprietary media formulations, and mitigate logistical challenges associated with custom media scale-up processes.
-
Leveraging dPCR r Techniques To Quantitate Lentivirus Particles
5/28/2025
Discover how digital PCR can streamline lentiviral vector characterization to reduce variability and improve analytical sensitivity. Learn how this approach can help you comply with regulatory guidance.
-
Understanding AI And Machine Learning's Impact On CGT with Dr. Peter Marks and Dr. Nicole Verdun
1/30/2024
During this segment, Dr. Peter Marks and Dr. Nicole Verdun share their take on how AI and machine learning will impact FDA regulation in 2024.
-
Maximize Your Drug Product Recovery With A Complete Fill Finish Solution
5/29/2025
Discover how to maximize drug product recovery with an end-to-end fill-finish solution. Get excellent integrity assurance and exceptional lead times for your critical processes.
-
A Collaboration With Fresenius Kabi BioPharm
5/19/2025
Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.
-
AAV Downstream Challenges: Expert Insights
5/22/2025
Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.
-
mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A
1/29/2024
During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.
-
Race To The Regulatory Finish Line: Dr. Nicole Verdun Talks Efficiencies In Platform Technologies
1/30/2024
Could a platform approach help certain therapies make their way over the regulatory finish line more efficiently?
-
Cytovance And Thermo Fisher Scientific Single-Use Equipment Collaboration
11/10/2025
This video highlights the success Cytovance has had solving complex issues with our Thermo Scientific imPULSE Single-Use Mixers (S.U.M.s) HyPerforma Single-Use Fermentors (S.U.F.s) and BioProcess Containers (BPCs).